Drugs@FDA: FDA-Approved Drugs
Biologic License Application (BLA): 761354
Company: BIOGEN MA
Company: BIOGEN MA
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
TOFIDENCE | TOCILIZUMAB-BAVI | 80MG/4ML | INJECTABLE;INJECTION | Prescription | None | No | No |
TOFIDENCE | TOCILIZUMAB-BAVI | 200MG/10ML | INJECTABLE;INJECTION | Prescription | None | No | No |
TOFIDENCE | TOCILIZUMAB-BAVI | 400MG/20ML | INJECTABLE;INJECTION | Prescription | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
09/29/2023 | ORIG-1 | Approval | N/A |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761354s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/761354Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/761354Orig1s000TOC.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
12/03/2024 | SUPPL-4 | Supplement |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/761354Orig1s004ltr.pdf |
07/22/2024 | SUPPL-2 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761354s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/761354Orig1s002ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
07/22/2024 | SUPPL-2 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761354s002lbl.pdf | |
07/22/2024 | SUPPL-2 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761354s002lbl.pdf | |
07/22/2024 | SUPPL-2 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761354s002lbl.pdf | |
09/29/2023 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761354s000lbl.pdf |